BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22491051)

  • 1. Second malignant neoplasms in testicular cancer survivors.
    Fung C; Fossa SD; Beard CJ; Travis LB
    J Natl Compr Canc Netw; 2012 Apr; 10(4):545-56. PubMed ID: 22491051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
    van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary malignant neoplasms in testicular cancer survivors.
    Curreri SA; Fung C; Beard CJ
    Urol Oncol; 2015 Sep; 33(9):392-8. PubMed ID: 26072728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Solid Cancer After Treatment of Testicular Germ Cell Cancer in the Platinum Era.
    Groot HJ; Lubberts S; de Wit R; Witjes JA; Kerst JM; de Jong IJ; Groenewegen G; van den Eertwegh AJM; Poortmans PM; Klümpen HJ; van den Berg HA; Smilde TJ; Vanneste BGL; Aarts MJ; Incrocci L; van den Bergh ACM; Jóźwiak K; van den Belt-Dusebout AW; Horenblas S; Gietema JA; van Leeuwen FE; Schaapveld M
    J Clin Oncol; 2018 Aug; 36(24):2504-2513. PubMed ID: 29989856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
    Travis LB; Fosså SD; Schonfeld SJ; McMaster ML; Lynch CF; Storm H; Hall P; Holowaty E; Andersen A; Pukkala E; Andersson M; Kaijser M; Gospodarowicz M; Joensuu T; Cohen RJ; Boice JD; Dores GM; Gilbert ES
    J Natl Cancer Inst; 2005 Sep; 97(18):1354-65. PubMed ID: 16174857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased pancreatic cancer risk following radiotherapy for testicular cancer.
    Hauptmann M; Børge Johannesen T; Gilbert ES; Stovall M; van Leeuwen FE; Rajaraman P; Smith SA; Weathers RE; Aleman BM; Andersson M; Curtis RE; Dores GM; Fraumeni JF; Hall P; Holowaty EJ; Joensuu H; Kaijser M; Kleinerman RA; Langmark F; Lynch CF; Pukkala E; Storm HH; Vaalavirta L; van den Belt-Dusebout AW; Morton LM; Fossa SD; Travis LB
    Br J Cancer; 2016 Sep; 115(7):901-8. PubMed ID: 27599043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy.
    van den Belt-Dusebout AW; Aleman BM; Besseling G; de Bruin ML; Hauptmann M; van 't Veer MB; de Wit R; Ribot JG; Noordijk EM; Kerst JM; Gietema JA; van Leeuwen FE
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1420-9. PubMed ID: 19931732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment-associated leukemia following testicular cancer.
    Travis LB; Andersson M; Gospodarowicz M; van Leeuwen FE; Bergfeldt K; Lynch CF; Curtis RE; Kohler BA; Wiklund T; Storm H; Holowaty E; Hall P; Pukkala E; Sleijfer DT; Clarke EA; Boice JD; Stovall M; Gilbert E
    J Natl Cancer Inst; 2000 Jul; 92(14):1165-71. PubMed ID: 10904090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second malignant neoplasms in long-term survivors of childhood rhabdomyosarcoma.
    Scaradavou A; Heller G; Sklar CA; Ren L; Ghavimi F
    Cancer; 1995 Nov; 76(10):1860-7. PubMed ID: 8625059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of testicular cancer and the development of secondary malignancies.
    Bokemeyer C; Schmoll HJ
    J Clin Oncol; 1995 Jan; 13(1):283-92. PubMed ID: 7799032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second malignant neoplasms and cardiovascular disease following radiotherapy.
    Travis LB; Ng AK; Allan JM; Pui CH; Kennedy AR; Xu XG; Purdy JA; Applegate K; Yahalom J; Constine LS; Gilbert ES; Boice JD
    J Natl Cancer Inst; 2012 Mar; 104(5):357-70. PubMed ID: 22312134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment.
    van Leeuwen FE; Ng AK
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):323-330. PubMed ID: 27913498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of second malignant neoplasms among long-term survivors of testicular cancer.
    Travis LB; Curtis RE; Storm H; Hall P; Holowaty E; Van Leeuwen FE; Kohler BA; Pukkala E; Lynch CF; Andersson M; Bergfeldt K; Clarke EA; Wiklund T; Stoter G; Gospodarowicz M; Sturgeon J; Fraumeni JF; Boice JD
    J Natl Cancer Inst; 1997 Oct; 89(19):1429-39. PubMed ID: 9326912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term complications following treatment of testicular cancer and Hodgkin lymphoma].
    van den Belt-Dusebout AW; Aleman BM; Gietema JA; de Wit R; van 't Veer MB; Lugtenburg PJ; Krol AD; van Leeuwen FE
    Ned Tijdschr Geneeskd; 2010; 154(45):A2229. PubMed ID: 21118593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up.
    Haugnes HS; Bosl GJ; Boer H; Gietema JA; Brydøy M; Oldenburg J; Dahl AA; Bremnes RM; Fosså SD
    J Clin Oncol; 2012 Oct; 30(30):3752-63. PubMed ID: 23008318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term risk of second malignant neoplasms after neuroblastoma in childhood: role of treatment.
    Rubino C; Adjadj E; Guérin S; Guibout C; Shamsaldin A; Dondon MG; Valteau-Couanet D; Hartmann O; Hawkins M; de Vathaire F
    Int J Cancer; 2003 Dec; 107(5):791-6. PubMed ID: 14566829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second malignant neoplasms and cardiovascular disease following radiotherapy.
    Travis LB; Ng AK; Allan JM; Pui CH; Kennedy AR; Xu XG; Purdy JA; Applegate K; Yahalom J; Constine LS; Gilbert ES; Boice JD
    Health Phys; 2014 Feb; 106(2):229-46. PubMed ID: 24378498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased stomach cancer risk following radiotherapy for testicular cancer.
    Hauptmann M; Fossa SD; Stovall M; van Leeuwen FE; Johannesen TB; Rajaraman P; Gilbert ES; Smith SA; Weathers RE; Aleman BM; Andersson M; Curtis RE; Dores GM; Fraumeni JF; Hall P; Holowaty EJ; Joensuu H; Kaijser M; Kleinerman RA; Langmark F; Lynch CF; Pukkala E; Storm HH; Vaalavirta L; van den Belt-Dusebout AW; Travis LB; Morton LM
    Br J Cancer; 2015 Jan; 112(1):44-51. PubMed ID: 25349972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second cancer risk in childhood cancer survivors treated with intensity-modulated radiation therapy (IMRT).
    Casey DL; Friedman DN; Moskowitz CS; Hilden PD; Sklar CA; Wexler LH; Wolden SL
    Pediatr Blood Cancer; 2015 Feb; 62(2):311-316. PubMed ID: 25328040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation-Related New Primary Solid Cancers in the Childhood Cancer Survivor Study: Comparative Radiation Dose Response and Modification of Treatment Effects.
    Inskip PD; Sigurdson AJ; Veiga L; Bhatti P; Ronckers C; Rajaraman P; Boukheris H; Stovall M; Smith S; Hammond S; Henderson TO; Watt TC; Mertens AC; Leisenring W; Stratton K; Whitton J; Donaldson SS; Armstrong GT; Robison LL; Neglia JP
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):800-7. PubMed ID: 26972653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.